@misc{oai:repo.qst.go.jp:00069320,
 author = {Imada, Hiroshi and Katou, Hirotoshi and Yamada, Shigeru and Yasuda, Shigeo and Hara, Ryusuke and Yanagi, Takeshi and Kamada, Tadashi and Mizoe, Junetsu and Tsujii, Hirohiko and et.al and 今田 浩史 and 加藤 博敏 and 山田 滋 and 安田 茂雄 and 原 竜介 and 柳 剛 and 鎌田 正 and 溝江 純悦 and 辻井 博彦},
 month = {Mar},
 note = {Hepatocellular carcinoma (HCC) is one of the most common malignant tumors throughout the world. The prognosis is still poor, and the 5-year survival rate is about 15% in Japan. Out of HCC patients, 85% are associated with liver cirrhosis, a very advanced hepatic disorder itself, and the patients often require repeated therapies owing to the intrahepatic metastasis and multicentric carcinogenesis in the cirhotic liver. Therefore, both radical effect and minimal invasiveness are essential for the treatment of HCC. However, no therapies have been available that satisfy both of the these essential requirements for every-sized tumor., 18th Conference of the Asian Pacific Association for the Study of the Liver},
 title = {Short-course Carbon Ion Radiotherapy for Hepatocellular Carcinoma: Evaluation of Liver Function in a Phase II Clinical Trial},
 year = {2008}
}